Trials / Completed
CompletedNCT00700999
Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)
Neurofunctional Markers of SSRI Treatment Response in PTSD
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- US Department of Veterans Affairs · Federal
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine if treatment of post-traumatic stress disorder in combat veterans with paroxetine changes brain responses as measured by functional magnetic resonance imaging and if brain responses can predict who will get better with treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine | Paroxetine 20-40mg po QD for 12 weeks |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2008-06-19
- Last updated
- 2014-06-03
- Results posted
- 2014-06-03
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00700999. Inclusion in this directory is not an endorsement.